Accuracy of initial stroke subtype diagnosis. A decision analysis

Cerebrovascular Diseases

Volumn 10, Issue 1, 2000, Pages 18-24

  Kasner, Scott E ^a,b   Kimmel, Stephen E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Decision modeling; Predictive value of tests; Stroke classification

Indexed keywords

DANAPAROID;

ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; HUMAN; MEDICAL DECISION MAKING; PATIENT SELECTION; PRIORITY JOURNAL; SIDE EFFECT; STROKE;

CEREBROVASCULAR ACCIDENT; DECISION SUPPORT TECHNIQUES; DECISION TREES; HUMANS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 0033974096     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016020     Document Type: Article

References (16)

1. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, and the TOAST Investigators: Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
2. Wahlgren NG, Clomethiazole Acute Stroke Study collaborative group: The Clomethiazole Acute Stroke Study (CLASS): Efficacy results in a subgroup of 545 patients with total anterior circulation syndrome (abstract). Stroke 1998;29:287.
3. Clark WM, Williams BJ, Selzer KA, Zweifler RM, Saboujian LA, for the Citicoline Study Group: Randomized efficacy trial of citicoline in acute ischemic stroke (abstract). Stroke 1998;29:287.
4. Hantson L, Wessel T: Therapeutic benefits of lubeluzole in ischemic stroke (abstract). Stroke 1998;29:287.
5. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators: Low molecular weight heparinoid, ORG 10172 (danaparoid) and outcome after acute ischemic stroke. JAMA 1998; 279:1265-1272.
6. Madden KP, Karanjia PN, Adams HP, Clarke WR, and the TOAST Investigators: Accuracy of initial stroke subtype diagnosis in the TOAST study. Neurology 1995;45:1975-1979.
7. Richardson WS, Detsky AS, for the Evidence-Based Working Group: User's guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and how will they help me in caring for my patients? JAMA 1995;273:1610-1613.
8. Richardson WS, Detsky AS, for the Evidence-Based Working Group: User's guides to the medical literature. VII. How to use a clinical decision analysis. A. Are the results of the study valid? JAMA 1995;273:1292-1295.
9. Pauker SG, Kassirer JP: Decision analysis. N Engl J Med 1987;316:250-258.
10. Pauker SG, Kassirer JP: The threshold approach to clinical decision making. N Engl J Med 1980;302:1109-1117.
11. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
12. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P, for the Second European-Australasian Acute Stroke Study Investigators: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245-1251.
13. Clark WM, Warach SJ, Pettigrew LC, Gammans RE, Sabounjian LA: A randomized dose-response trial of citicoline in acute ischemic stroke patients: Citicoline Stroke Study Group. Neurology 1997;49:671-678.
14. Solomon NA, Glick HA, Russo DJ, Lee J, Schulman KA: Patient preferences for stroke outcomes. Stroke 1994;25:1721-1725.
15. Gage BF, Cardinalli AB, Albers GW, Owens DK: Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with non-valvular trial fibrillation. JAMA 1995;274: 1839-1845.
16. Kelsey JL, Thompson WD, Evans AS: Methods in Observational Epidemiology. New York, Oxford University Press, 1986.